EVLO Evelo Biosciences Inc

0.00 (0.0%)
Last Updated: 15:44:01
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 40,396
Bid Price 3.96
Ask Price 4.06
News -
Day High 4.25


52 Week Range


Day Low 3.9218
Company Name Stock Ticker Symbol Market Type
Evelo Biosciences Inc EVLO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.00 15:44:01
Open Price Low Price High Price Close Price Prev Close
4.06 3.9218 4.25 4.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
358 40,396 $ 4.04 $ 163,310 - 1.586 - 48.40
Last Trade Time Type Quantity Stock Price Currency
15:46:38 1 $ 3.99 USD

Evelo Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
75.34M 18.84M - 0 -114.53M -6.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Evelo Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No EVLO Message Board. Create One! See More Posts on EVLO Message Board See More Message Board Posts

Historical EVLO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.334.433.574.00113,220-0.33-7.62%
1 Month6.637.68923.575.36113,589-2.63-39.67%
3 Months2.5713.932.317.90612,1751.4355.64%
6 Months4.3413.931.5863.525,663,280-0.34-7.83%
1 Year39.4048.401.5864.012,909,196-35.40-89.85%
3 Years102.00398.5661.58626.951,153,048-98.00-96.08%
5 Years245.20398.5661.58631.00720,711-241.20-98.37%

Evelo Biosciences Description

Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.
Your Recent History
Evelo Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now